Navigation Links
Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Date:7/10/2009

SANTA FE and ALBUQUERQUE, N.M., July 10 /PRNewswire/ -- Daniel Ronel, M.D., a board-certified plastic surgeon, has selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines, to treat patients who are looking for a longer lasting dermal filler. Dr. Ronel has been an avid Artefill user the past several years due to its proven success and effectiveness for the correction of wrinkles.

He says, "My patients love the fact that their wrinkle correction can last for years with Artefill, and I enjoy using it because it is silky smooth, versatile, and clear. In this economy, people are grateful that they do not need to come back repeatedly to pay for more filler! I have found that each syringe of Artefill goes a long way."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide the support the skin needs for long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Artefill is only offered by a select group of physicians in the Southwest and is not available at all physician offices. Dr. Ronel is one of the company trained and select few company sponsored physicians who has the skills and experience needed to administer the product.

Elizabeth Ferrell, a patient of Dr. Ronel's said, "Artefill was the logical choice for me -- I've had deep lines ever since I was a teenager and I was frustrated at having to go back and forth for more injections. Dr. Ronel's technique, with all the holistic things he does, actually made the whole experience pleasant. My family and friends were very impressed, and felt the same way after they went in themselves."

About Artefill:

Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in 2006, over 10 thousand patients have been treated successfully with very high satisfaction rates.

Suneva Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets, markets and manufactures Artefill. The Company was formed in April 2009 to deliver the same great product that physicians and patients have embraced over the past several years. For more information visit www.artefill.com or www.sunevamedical.com.

DR. DANIEL RONEL is a board-certified plastic surgeon with offices in Santa Fe and Albuquerque NM. Educated and trained at Princeton, Penn, Columbia, Cornell, and Harvard, he is the only surgeon in the U.S. who is board certified in both plastic surgery and pediatrics. Dr. Ronel was named one of America's Top Plastic Surgeons by the Consumer's Research Council of America. Because of his combined expertise in pediatrics and plastic surgery, Dr. Ronel is one of 13 national experts selected by Allergan to sit on the Breast Implant Research Team, an advisory panel on silicone breast implants. Dr. Ronel is a member of the Radiesse Medical Education Facility, a group composed of approximately 120 physicians from across the United States who are experts in the field of injectable fillers. He was voted Albuquerque's Plastic Surgeon of the Year in 2007 by readers of The Herald, and was named one of Albuquerque's 2007 Top Docs by Albuquerque, the Magazine. He can be found on the web at www.danielronelmd.com.

ATTENTION MEDIA: To download Artefill patient before and after pictures visit http://www.artefill.com/content/c/beforeandafter/overview.asp

    Contact:
    Daniel Ronel, M.D.
    Office: 505-982-2440
    Cell: 505-690-5337
    info@danielronelmd.com


'/>"/>
SOURCE Daniel Ronel, M.D.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. PPD Names Daniel Darazsdi as Chief Financial Officer
3. OmniSonics Appoints J. Daniel Cole Chairman of the Board
4. Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board
5. Ikaria Appoints Daniel Tasse as President and Chief Executive Officer
6. CNS Response, Inc Completes Neuro-Therapy Clinic Acquisition; Names Daniel A. Hoffman, MD Chief Medical Officer
7. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
8. Anesiva Appoints Daniel Janney to Board of Directors
9. Egenix, Inc. Appoints Dr. Daniel Petrylak Chairman of Scientific Advisory Board
10. Daniel B. Dubin, M.D., Joins NanoBio Corp.s Board of Directors
11. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected ... of 7.3% during the forecast period of 2016 to 2021 dominated ... accounted for the largest share of immunohistochemistry (IHC) market, by end ... , , ... market spread across 225 pages, profiling 10 companies and supported with ...
(Date:11/30/2016)... 30, 2016 The global Pyrogen ... hold a dominant share in the overall market. The ... Inc., and Merck KGaA, held a lion,s share of ... Research observes that these companies are expected to retain ... that are do not require rabbit pyrogen testing along ...
(Date:11/30/2016)... 30, 2016 /PRNewswire/ -  Equicare Health Inc ., the ... recognized as one of the top 100 companies in ... listing that distinguishes the top digital health companies across ... step forward this year continually upgrading our product with ... base and team," says Len Grenier , CEO ...
(Date:11/30/2016)... 2016 Part of 5m$ Investment in ... ... Aptuit, LLC today announced that it had successfully completed the ... compounds have increased the Screening Collection to over 400,000. The ... capabilities of the company. This expansion, complemented by new robotics ...
Breaking Biology Technology:
(Date:11/22/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the company ... Life Sciences Awards as "Most Outstanding in eClinical ... year of recognition and growth for MedNet, which has ... iMedNet ™ , MedNet,s flagship ...
(Date:11/17/2016)... Calif. , Nov. 17, 2016  AIC announces that it has just released ... in organizations that require high-performance scale-out plus high speed data transfer storage solutions. ... ... ... Setting up a high ...
(Date:11/14/2016)... Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), ... in challenging operating environments, announced its results for the ... a conference call to discuss these results on November ... Key Recent Accomplishments ... acquire Vislink Communication Systems. The purchase is expected to ...
Breaking Biology News(10 mins):